Search for: "WYETH PHARMACEUTICALS INC"
Results 441 - 460
of 515
Sort by Relevance
|
Sort by Date
7 Jul 2008, 10:59 am
Wyeth Canada Inc., 2008 BCSC 847 (June 27, 2008). [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
26 Jun 2008, 6:31 pm
Breckenridge Pharmaceutical, Inc., 388 F. [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP) Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
4 Jun 2008, 8:32 pm
TNF blockers currently approved for pediatric use include etanercept (Enbrel, Immunex Corp, marketed by Amgen and Wyeth Pharmaceuticals), adalimumab (Humira, Abbott Laboratories), and infliximab (Remicade, Centocor, Inc). [read post]
29 May 2008, 10:00 am
We posted Wyeth's principal brief in Wyeth v. [read post]
23 May 2008, 10:17 pm
Philip Morris USA, Inc., 142 P.3d 1079 (Or. [read post]
23 May 2008, 1:03 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Indian Patent Office decisions now searchable and downloadable: (Indian Patent Oppositions), (Generic Pharmaceuticals & IP), (Spicy IP), Institute for Progress study on inter partes re-examination: (Peter Zura's 271 Patent Blog), (IAM), (Hal Wegner) Nintendo loses patent suit over 3D controller; Anascape awarded $21M in damages:… [read post]
12 May 2008, 2:46 pm
Looking forward, in October 2008 (what will likely still be) the same Supreme Court hears oral arguments in the case Wyeth v. [read post]
8 May 2008, 12:22 pm
Wyeth Pharmaceuticals, 2008 WL 1821379 (5th Cir. [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
10 Apr 2008, 9:45 am
When Medtronic, Inc. v. [read post]
3 Apr 2008, 7:27 am
Wyeth Pharmaceuticals, Inc., 2007 WL 4673679 (Pa. [read post]
20 Mar 2008, 10:29 am
Wyeth Pharmaceuticals, 530 F. [read post]
19 Mar 2008, 6:04 am
(Then again, maybe the academics will distinguish themselves from us by saying something worthwhile.)Anyway, we're moving on from Riegel, at least for today, and looking ahead to the blockbuster pharmaceutical preemption case that the Supreme Court will decide next Term, Wyeth v. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
